Alpine Woods Capital Investors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.23M | Buy |
2,463
+36
| +1% | +$17.3K | 0.27% | 85 |
|
|
2026
Q1 | $1.19M | Buy |
2,427
+1,534
| +172% | +$833K | 0.29% | 80 |
|
|
2025
Q4 | $517K | Sell |
893
-50
| -5% | -$28.3K | 0.12% | 124 |
|
|
2025
Q3 | $457K | Buy |
943
+18
| +2% | +$8.38K | 0.11% | 115 |
|
|
2025
Q2 | $375K | Sell |
925
-8,488
| -90% | -$3.55M | 0.09% | 128 |
|
|
2025
Q1 | $4.68M | Sell |
9,413
-4,267
| -31% | -$2.31M | 1.17% | 29 |
|
|
2024
Q4 | $7.12M | Buy |
13,680
+2,300
| +20% | +$1.26M | 1.35% | 19 |
|
|
2024
Q3 | $6.22M | Sell |
11,380
-3,215
| -22% | -$1.9M | 1.09% | 29 |
|
|
2024
Q2 | $8.07M | Buy |
14,595
+3,216
| +28% | +$1.84M | 1.24% | 24 |
|
|
2024
Q1 | $6.47M | Sell |
11,379
-5,905
| -34% | -$3.31M | 1.29% | 22 |
|
|
2023
Q4 | $9.17M | Buy |
17,284
+996
| +6% | +$482K | 1.37% | 14 |
|
|
2023
Q3 | $8.24M | Buy |
16,288
+2,977
| +22% | +$1.59M | 1.33% | 20 |
|
|
2023
Q2 | $6.95M | Sell |
13,311
-617
| -4% | -$333K | 1.09% | 32 |
|
|
2023
Q1 | $8.03M | Sell |
13,928
-899
| -6% | -$507K | 1.21% | 25 |
|
|
2022
Q4 | $8.16M | Sell |
14,827
-1,604
| -10% | -$850K | 1.19% | 30 |
|
|
2022
Q3 | $8.33M | Buy |
16,431
+20
| +0.1% | +$11.2K | 1.13% | 27 |
|
|
2022
Q2 | $8.92M | Sell |
16,411
-16
| -0.1% | -$8.81K | 1.12% | 28 |
|
|
2022
Q1 | $9.7M | Sell |
16,427
-150
| -0.9% | -$86.2K | 1.02% | 26 |
|
|
2021
Q4 | $11.1M | Sell |
16,577
-394
| -2% | -$246K | 1.09% | 24 |
|
|
2021
Q3 | $9.7M | Sell |
16,971
-490
| -3% | -$269K | 1.04% | 25 |
|
|
2021
Q2 | $8.81M | Buy |
17,461
+4,196
| +32% | +$1.98M | 0.91% | 33 |
|
|
2021
Q1 | $6.05M | Sell |
13,265
-344
| -3% | -$164K | 0.67% | 51 |
|
|
2020
Q4 | $6.34M | Buy |
13,609
+560
| +4% | +$263K | 0.77% | 40 |
|
|
2020
Q3 | $5.76M | Buy |
13,049
+287
| +2% | +$119K | 0.87% | 32 |
|
|
2020
Q2 | $4.62M | Sell |
12,762
-347
| -3% | -$116K | 0.89% | 22 |
|
|
2020
Q1 | $3.72M | Buy |
13,109
+945
| +8% | +$298K | 0.83% | 27 |
|
|
2019
Q4 | $3.95M | Buy |
12,164
+2,300
| +23% | +$697K | 0.75% | 26 |
|
|
2019
Q3 | $2.87M | Hold |
9,864
| – | – | 0.53% | 40 |
|
|
2019
Q2 | $2.9M | Buy |
9,864
+1,200
| +14% | +$331K | 0.6% | 38 |
|
|
2019
Q1 | $2.37M | Buy |
8,664
+2,254
| +35% | +$561K | 0.52% | 48 |
|
|
2018
Q4 | $1.43M | Sell |
6,410
-170
| -3% | -$39.9K | 0.34% | 71 |
|
|
2018
Q3 | $1.61M | Hold |
6,580
| – | – | 0.33% | 77 |
|
|
2018
Q2 | $1.36M | Sell |
6,580
-71,170
| -92% | -$15.1M | 0.3% | 81 |
|
|
2018
Q1 | $16.1M | Sell |
77,750
-8,500
| -10% | -$1.78M | 0.85% | 24 |
|
|
2017
Q4 | $16.4M | Hold |
86,250
| – | – | 0.82% | 31 |
|
|
2017
Q3 | $16.3M | Hold |
86,250
| – | – | 0.83% | 31 |
|
|
2017
Q2 | $15M | Hold |
86,250
| – | – | 0.8% | 37 |
|
|
2017
Q1 | $13.2M | Hold |
86,250
| – | – | 0.71% | 41 |
|
|
2016
Q4 | $12.2M | Sell |
86,250
-900
| -1% | -$133K | 0.67% | 45 |
|
|
2016
Q3 | $13.9M | Hold |
87,150
| – | – | 0.77% | 41 |
|
|
2016
Q2 | $12.9M | Hold |
87,150
| – | – | 0.77% | 44 |
|
|
2016
Q1 | $12.3M | Sell |
87,150
-42,300
| -33% | -$5.67M | 0.72% | 46 |
|
|
2015
Q4 | $18.4M | Sell |
129,450
-8,500
| -6% | -$1.13M | 0.99% | 22 |
|
|
2015
Q3 | $16.9M | Sell |
137,950
-15,000
| -10% | -$1.95M | 0.92% | 23 |
|
|
2015
Q2 | $19.8M | Hold |
152,950
| – | – | 1.01% | 16 |
|
|
2015
Q1 | $20.5M | Sell |
152,950
-2,800
| -2% | -$361K | 1.05% | 14 |
|
|
2014
Q4 | $19.5M | Buy |
155,750
+25,100
| +19% | +$3.05M | 1% | 22 |
|
|
2014
Q3 | $15.9M | Hold |
130,650
| – | – | 0.85% | 39 |
|
|
2014
Q2 | $15.4K | Buy |
130,650
+41,500
| +47% | +$4.88M | 0.4% | 46 |
|
|
2014
Q1 | $10.7M | Hold |
89,150
| – | – | 0.59% | 60 |
|
|
2013
Q4 | $9.93M | Hold |
89,150
| – | – | 0.57% | 63 |
|
|
2013
Q3 | $8.21M | Hold |
89,150
| – | – | 0.5% | 67 |
|
|
2013
Q2 | $7.54M | Buy |
+89,150
| New | +$7.42M | 0.48% | 68 |
|
Other funds holding TMO
Alpine Woods Capital Investors's TMO Position: Q2 2026 in Review
Alpine Woods Capital Investors increased its Thermo Fisher Scientific (TMO) stake by 1.5% in Q2 2026, buying an estimated $17.3K and bringing the position to 2,463 shares worth $1.23M. The position accounts for 0.27% of the portfolio, ranked #85.
Alpine Woods Capital Investors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $20.5M in Q1 2015. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Alpine Woods Capital Investors held 2,463 shares of Thermo Fisher Scientific worth $1.23M as of Q2 2026.
- Alpine Woods Capital Investors bought 36 Thermo Fisher Scientific shares in Q2 2026, an estimated $17.3K.
- Thermo Fisher Scientific made up 0.27% of Alpine Woods Capital Investors's portfolio in Q2 2026, its #85 holding.
- Alpine Woods Capital Investors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Alpine Woods Capital Investors's Thermo Fisher Scientific position peaked at $20.5M in Q1 2015.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.